IL107870A - Pharmaceutical preparations containing permifaxol with antidepressant activity - Google Patents

Pharmaceutical preparations containing permifaxol with antidepressant activity

Info

Publication number
IL107870A
IL107870A IL10787093A IL10787093A IL107870A IL 107870 A IL107870 A IL 107870A IL 10787093 A IL10787093 A IL 10787093A IL 10787093 A IL10787093 A IL 10787093A IL 107870 A IL107870 A IL 107870A
Authority
IL
Israel
Prior art keywords
amino
propyl
pramipexol
acid addition
pharmacologically acceptable
Prior art date
Application number
IL10787093A
Other languages
English (en)
Hebrew (he)
Other versions
IL107870A0 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL107870A0 publication Critical patent/IL107870A0/xx
Publication of IL107870A publication Critical patent/IL107870A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL10787093A 1992-12-05 1993-12-03 Pharmaceutical preparations containing permifaxol with antidepressant activity IL107870A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung

Publications (2)

Publication Number Publication Date
IL107870A0 IL107870A0 (en) 1994-04-12
IL107870A true IL107870A (en) 1996-12-05

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10787093A IL107870A (en) 1992-12-05 1993-12-03 Pharmaceutical preparations containing permifaxol with antidepressant activity

Country Status (29)

Country Link
US (1) US6191153B1 (fr)
EP (1) EP0675717B1 (fr)
JP (1) JP3221880B2 (fr)
KR (1) KR100311165B1 (fr)
CN (1) CN1052400C (fr)
AT (1) ATE183091T1 (fr)
AU (1) AU674378B2 (fr)
BG (1) BG62475B1 (fr)
CA (1) CA2150131C (fr)
CZ (1) CZ282679B6 (fr)
DE (2) DE4241013A1 (fr)
DK (1) DK0675717T3 (fr)
ES (1) ES2136725T3 (fr)
FI (1) FI952734A0 (fr)
GR (1) GR3031521T3 (fr)
HK (1) HK1019003A1 (fr)
HU (1) HU221014B1 (fr)
IL (1) IL107870A (fr)
MX (1) MX9307644A (fr)
NO (1) NO306930B1 (fr)
NZ (1) NZ258876A (fr)
PL (1) PL309282A1 (fr)
RU (1) RU2157685C2 (fr)
SG (1) SG49228A1 (fr)
SK (1) SK281441B6 (fr)
TW (1) TW362973B (fr)
UA (1) UA35604C2 (fr)
WO (1) WO1994013287A1 (fr)
ZA (1) ZA939065B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (fr) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent antidepresseur
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
AU7887501A (en) * 2000-07-06 2002-01-21 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (fr) * 2001-05-23 2002-12-18 Pfizer Products Inc. Therapie de combinaison de la depression et de l'anxieté
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
DE102004006808A1 (de) * 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
NZ553645A (en) * 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
CN101005830B (zh) * 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂、其制备方法及用途
BRPI0607684A2 (pt) * 2005-04-04 2009-09-22 Takeda Pharmaceutical composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
CA2626249A1 (fr) * 2005-10-18 2007-04-26 Boehringer Ingelheim International Gmbh Utilisation de pramipexol pour traiter le syndrome des jambes sans repos (rls) modere a severe
JP2009526021A (ja) * 2006-02-10 2009-07-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 放出を加減した製剤
WO2007090883A1 (fr) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Formulation à libération prolongée
MA51658A (fr) * 2017-04-10 2020-12-02 Chase Therapeutics Corp Association comprenant un antagoniste de nk1 et méthode de traitement de synucléinopathies
EP3645120A4 (fr) * 2017-06-30 2021-03-24 Chase Pharmaceuticals Corporation Compositions d'antagoniste de nk-1 et méthodes destinées à être utilisées dans le traitement de la dépression
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
AU5715294A (en) 1994-07-04
NO952207L (no) 1995-06-02
FI952734A (fi) 1995-06-05
SG49228A1 (en) 1998-05-18
JP3221880B2 (ja) 2001-10-22
TW362973B (en) 1999-07-01
IL107870A0 (en) 1994-04-12
KR100311165B1 (ko) 2001-12-28
SK74095A3 (en) 1996-05-08
JPH08504201A (ja) 1996-05-07
DK0675717T3 (da) 2000-02-28
HK1019003A1 (en) 2000-01-14
NO952207D0 (no) 1995-06-02
CZ144095A3 (en) 1996-03-13
CA2150131C (fr) 2004-09-21
HU221014B1 (hu) 2002-07-29
WO1994013287A1 (fr) 1994-06-23
BG99700A (bg) 1996-04-30
CN1091635A (zh) 1994-09-07
ZA939065B (en) 1994-08-04
CN1052400C (zh) 2000-05-17
RU2157685C2 (ru) 2000-10-20
UA35604C2 (uk) 2001-04-16
GR3031521T3 (en) 2000-01-31
ATE183091T1 (de) 1999-08-15
NO306930B1 (no) 2000-01-17
MX9307644A (es) 1994-06-30
HU9501623D0 (en) 1995-08-28
EP0675717A1 (fr) 1995-10-11
HUT71798A (en) 1996-02-28
KR950703953A (ko) 1995-11-17
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (fr) 1999-08-11
SK281441B6 (sk) 2001-03-12
US6191153B1 (en) 2001-02-20
PL309282A1 (en) 1995-10-02
DE59309733D1 (de) 1999-09-16
CA2150131A1 (fr) 1994-06-23
FI952734A0 (fi) 1995-06-05
ES2136725T3 (es) 1999-12-01
DE4241013A1 (de) 1994-06-09
NZ258876A (en) 1997-07-27
BG62475B1 (bg) 1999-12-30
AU674378B2 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
CA2150131C (fr) Utilisation de l'amino-2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole comme composition pharmaceutique possedant une activite d'antidepresseur
EP0209689B1 (fr) Utilisation des tétrahydrobioptérines pour l'obtention d'un médicament pour le traitement de l'autisme infantile
FI101040B (fi) Menetelmä sentraalisten dopamiininpuutostilojen hoitoon tarkoitetun, p eroraalisesti annettavan lääkemuodon valmistamiseksi
KR20090021169A (ko) Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
EP1181935B1 (fr) Utilisation d'Olanzapine pour le traitement de maladies mentales résultant de maladies cérébrovasculaires
EP0500851B1 (fr) Procede de preparation d'une composition sous forme de comprime ou de dragee comportant un ingredient actif thermosensible, photosensible et sensible a l'humidite presentant une structure cristalline monoclinique
LT3119B (en) Pharmaceutical composition and process for the preparation thereof
JPS63270626A (ja) 抗潰瘍剤
EP0319074B1 (fr) Composition pharmaceutique et procédé de sa préparation
EP0273253A2 (fr) L'emploi de 6-allyl-2-amino-5,6,7,8-tétrahydro-4H-thiazolo-[5,4d]azépine pour la libération de l'hormone somatotrope
EP0216072B1 (fr) Utilisation de dérivés de la dibenz[cd,f]indole pour la prévention de l'abus d'alcool
JPS6056974A (ja) 環式ジチオジアセトアミドおよびその製造方法並びに薬剤
CA2152280C (fr) Utilisation du riluzole comme radiorestaurateur
JPH11130672A (ja) 脂質過酸化抑制剤
US5238946A (en) Therapeutic agent for gastritis
KR950005869B1 (ko) 위염 치료제
EP0124150B1 (fr) Dérivés de benzocyclononanamine doués d'une activité anticonvulsive
EP0946181B1 (fr) Utilisation de 2(2-morpholinophenyl)guanidine derives pour le traitement de complications aux differents diabetes
JPH0466529A (ja) 細胞変性抑制並びに臓器毒性軽減剤
JPH01168615A (ja) 制吐作用薬剤
IL112062A (en) Pharmaceutical preparations containing derivatives of 2-methylamino-2-phenylcyclohexanone
JPH03200727A (ja) 喘息治療剤
TOTHENIC et al. Calcium hydrogen phosphate. Source
JPH0881374A (ja) 皮膚そう痒症の予防または治療薬
MXPA00012880A (en) Agents with an antidepressive effect

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired